Danish university places hold on controversial U.S. CDC hepatitis B vaccine study in Guinea-Bissau
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
On Jan. 23, 2026, public-health authorities in Guinea-Bissau say that they have suspended a controversial US-funded hepatitis B…
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Jun. 19, 2021, the Ebola outbreak that emerged in Guinea in mid-February was declared over. It was…
On Oct. 14, 2020, the FDA approved Regeneron Pharmaceutical’s Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three…
On Apr. 16, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…